LC/MS/MS를 이용한 산화성 스트레스 지표로써 소변 중 8-iso-PGF2α 분석

키워드

참고문헌 (33)

1. Block, G, "Factors associated with oxidative stress in human populations", American Journal of Epidemiology, 156(3), pp.274~285 (2002)
2. Mukai, F. F, "Mutagenicity of malonaldehyde,a decomposition product of peroxidized polyunsaturated fatty acids", Science, 191, pp.868~869 (1976)
3. Reilly, M, "Modulation of oxidant stress in vivo in chronic cigarette smokers", Circulation, 94(1), pp.19~25 (1996)
4. Dimopoulos, N, "Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression", Psychiatry Research, 161, pp.59~66 (2008)
5. Cavalca, V, "Simultaneous quantification of 8-iso-prostaglandin-F2α and 11-dehydro thromboxane B2 in human urine by liquid chromatography tandem mass spectrometry", Analytical Biochemistry, 397, pp.168~174 (2010)
6. Roxach, J, "The isoprostanes:A perspective", Prostaglandins, 54, pp.823~851 (1997)
7. Morrow, J. D, "Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids", Analytical Biochemistry, 184(1), pp.1~10 (1990)
8. Favreau, F, "Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemiareperfusion", Free Radical Biology and Medicine, 36(8), pp.1034~1042 (2004)
9. Hozawa, A, "Increased plasma 8-isoprostane levels in hypertensive subjects: the tsurugaya project", Hypertension Research, 27(8), pp.557~561 (2004)
10. Reilly, M. P, "Urinary 8-EPI PGF2α: an index of oxidant stress in vivo", Fibrinolysis and Proteolysis, 11, pp.81~84 (1997)
11. Ahmadzadehfar, H, "Passive cigarette smoking increases isoprostane formation", Life Sciences, 78(8), pp.894~897 (2006)
12. Helmersson, J, "Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men", Atherosclerosis, 181(1), pp.201~207 (2005)
13. Hill, D. B, "Increased urinary F2-isoprostane excretion in alcoholic liver disease", Free Radical Biology and Medicine, 26(5-6), pp.656~660 (1999)
14. Irizarry, M. C, "Biomarkers of alzheimer disease in plasma", NeuroRX, 1(2), pp.226~234 (2004)
15. Praticò, D, "F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases", Chemistry and Phys ics of Lipids, 128(1-2), pp.165~171 (2004)
16. Montuschi, P, "Exhaled 8-Isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", American Journal of Respiratory and Critical Care Medicine, 162, pp.1175~1177 (2000)
17. Hong, Y, "Community level exposure to chemicals and oxidative stress in adult population", Toxicology Letters, 184, pp.139~144 (2009)
18. Park, E, "Maternal exposure to environmental tobacco smoke, GSTM1", T1 polymorphisms and oxidative stress, 2008, pp.26, 197~202
19. Shin, M, "Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2α determinant", Metabolism, 55, pp.918~922 (2006)
20. Kim, K, "Increased urinary F2-isoprostanes levels in the patients with Alzheimer's disease", Brain Research Bulletin, 64, pp.47~51 (2004)
21. Kim, K, "Elevated urinary 8-isoprostaglandin F2α in females with Graves’ hyperthyroidism, Prostaglandins", Leukotrienes and Essential Fatty Acids, 71, pp.143~147 (2004)
22. Lawson, J. A, "Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo", Journal of Biological Chemistry, 275(44), pp.24441~24444 (1999)
23. Devaraj, S, "Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes", Clinical Chemistry, 47(11), pp.1974~1979 (2001)
24. Il'yasova, D, "Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography", mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane, 2004, pp.14(10), 793~797
25. Proudfoot, J, "Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzymeimmunoassay with gas chromatography", mass spectrometry, 1999, pp.272(2), 209~215
26. Davies, S. S, "Quantification of dinor,dihydro metabolites of F2-isoprostanes in urine by liquid chromatography", tandem mass spectrometry, 2006, pp.348(2), 185~191
27. Ohashi, N, "Rapid and sensitive quantification of 8-isoprostaglandin F2α in human plasma and urine by liquid chromatography?electrospray ionization mass spectrometry", Journal of Chromatography B: Biomedical Sciences and Applications, 746(1), pp.17~24 (2000)
28. Liang, Y, "Quantification of 8-iso-prostaglandin-F2α and 2,3-dinor-8-isoprostaglandin- F2α in human urine using liquid chromatography-tandem mass spectrometry", Free Radical biology & Medicine, 34(4), pp.409~418 (2003)
29. Bohnstedt, K. C, "Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography- tandem mass spectrometry", Journal of Chromatography B, 796, pp.11~19 (2003)
30. FDA, "Validation of analytical procedures:Methodology, recommended for implementation at step 7 of the VICH process on 22 October 1998 by the VICH steering committee, FDA, DHHS", ~ (1998)
31. Mucha,I, "Determination of 9α,11β-prostaglandin F2 in human urine. Combination of solidphase extraction and radioimmunoassay, Prostaglandins", Leukotrienes and Essential Fatty Acids, 65(5-6), pp.271~280 (2001)
32. Dillon, S. A., "Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F2 in smoking and nonsmoking men and women", Human Nutrition and Metabolism Research Communication, 132, pp.168~171 (2002)
33. Lee, C. J, "Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry", Biochemical and Biophysical Research Communications, 320, pp.696~670 (2004)

관련 논문AI추천